Loading stock data…
TDOC
$6.46+0.40 (+6.60%)
Market ClosedLast close May 1
Teladoc Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Teladoc Health, Inc. in the Healthcare sector is trading at $6.46. The stock is currently 34% below its 52-week high of $9.77, remaining 6.1% below its 200-day moving average. Technical signals show overbought RSI of 76 and bullish MACD crossover, explaining why TDOC maintains its current current market pressure. The Whystock Score of 10/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 76) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$6.46
Potential Upside
5%
Whystock Fair Value$6.78
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus21 analysts
Buy
Mean target$7.10+9.8%
Range$5.00 – $10.00
Fundamentals
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical se...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.07B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.08
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-14.96%
Volume
Today's trading volume
9.17M
Recent News
Teladoc Health Q1 Earnings Call Highlights
Teladoc Health (NYSE:TDOC) reported first-quarter 2026 results that Chief Executive Officer Chuck Divita said came in above the midpoint of the company’s guidance for both revenue and Adjusted EBITDA, driven by solid performance in Integrated Care and continued progress scaling BetterHelp’s insuranc
TDOC Q1 Deep Dive: AI-Enabled Product Rollout and Insurance Expansion Drive Strategic Shifts
Digital medical services platform Teladoc Health (NYSE:TDOC) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 2.5% year on year to $613.8 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $611.5 million was less impressive, coming in 2% below expectations. Its GAAP loss of $0.36 per share was 3.6% below analysts’ consensus estimates.
HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now?
Hims & Hers and Teladoc Health are taking different paths in digital health, but which stock offers stronger upside now? Let's dive in.
How Teladoc’s Narrower Q1 Loss Amid Softer Revenue At Teladoc Health (TDOC) Has Changed Its Investment Story
Teladoc Health, Inc. recently reported first-quarter 2026 results, with sales of US$613.85 million versus US$629.37 million a year earlier and a net loss of US$63.84 million compared with US$93.01 million. While revenue slipped, the reduced net loss and lower loss per share highlight Teladoc’s efforts to tighten operations and move closer to breakeven. We’ll now examine how Teladoc’s lower quarterly net loss, despite softer revenue, may influence its existing investment narrative and...
Teladoc Health, Inc. Q1 2026 Earnings Call Summary
Moby summary of Teladoc Health, Inc.'s Q1 2026 earnings call